Anxious Samsung Biologics... Three-Party Talks Remain Deadlocked
New Proposals Exchanged at Three-Party Meeting on May 19
Differences Remain; No Common Ground Found
While Samsung Electronics narrowly avoided a general strike, Samsung Biologics and its union are still struggling to find a way out, repeatedly confirming only their differences in stance. The protracted nature of the dispute is causing growing concerns as complex issues such as wages, workforce management, and union participation in management remain entangled.
According to industry sources on May 21, Samsung Biologics and its union held a tripartite meeting mediated by the Ministry of Employment and Labor on May 19 and exchanged new proposals, but failed to reach a compromise. As a result, a follow-up meeting scheduled for May 20 was canceled without a new date being set. The management stated, "The company has continued to present the best possible proposals, but unfortunately, we have not been able to reach an agreement," and added, "We will continue to communicate with the union and the government and do our utmost to complete the negotiations."
The Samsung Biologics union launched a partial strike on April 28, held the first general strike from May 1 to 5, and has been engaged in an indefinite work-to-rule action by refusing overtime and holiday shifts since May 6. The union has also not ruled out the possibility of a second general strike.
It has been pointed out that the labor-management negotiations at Samsung Biologics are unfolding differently from those at Samsung Electronics, presenting a far more complex situation. While the Samsung Electronics negotiations were centered on bonuses, the issues at Samsung Biologics are more deeply intertwined with not only wages but also workforce management and collective bargaining, impacting overall management. Park Jaeseong, head of the Samsung Biologics Win-Win Branch of the Samsung Group Super Enterprise Union, said in a phone interview, "The complexity of the negotiations means it will take more time."
The union is demanding a 14.3% increase in base salary, a flat increase of 3.5 million won, a settlement bonus of 30 million won per person, and a 20% share of operating profit as a performance bonus. In addition, the union is demanding that labor and management jointly determine the appropriate workforce size based on data and reflect this in the recruitment plan for the following year. They are also insisting on clauses in the collective agreement requiring union notification for executive appointments, union consent for workforce assignments or profit sharing, and union review and approval in the event of a company split or outsourcing.
The management has countered with a proposal to raise wages by 6.2% and pay a lump sum of 6 million won. However, the company maintains that demands other than wages and performance bonuses fall under the exclusive rights of management and therefore cannot be accepted.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Legal disputes are also exacerbating the conflict. The company has filed complaints against Park Jaeseong and six other union executives, as well as one union member, on charges of obstruction of business. The grounds for the complaint are that the strike continued despite a court order restricting industrial action in final processes intended to prevent spoilage and contamination. The company estimated that the first general strike resulted in losses exceeding 150 billion won, including the suspension of production of some products such as anticancer drugs. In response, the union has filed countercharges against certain members of management for unfair labor practices.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.